Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects

This study has been completed.
Information provided by (Responsible Party):
Amgen Identifier:
First received: September 29, 2011
Last updated: January 13, 2016
Last verified: January 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2015
  Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: January 13, 2016